Repression of Sox9 by Jag1 is continuously required to suppress the default chondrogenic fate of vascular smooth muscle cells

Developmental Cell

Volumn 31, Issue 6, 2014, Pages 707-721

  Briot, Anaïs ^a   Jaroszewicz, Artur ^a   Warren, Carmen M ^a   Lu, Jing ^a   Touma, Marlin ^b   Rudat, Carsten ^c   Hofmann, Jennifer J ^a   Airik, Rannar ^c   Weinmaster, Gerry ^a,b   Lyons, Karen ^a   Wang, Yibin ^b   Kispert, Andreas ^c   Pellegrini, Matteo ^a   Iruela Arispe, M Luisa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

JAGGED1; NOTCH RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX1; TRANSCRIPTION FACTOR SCX; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; LIGAND; MEMBRANE PROTEIN; SERRATE PROTEINS; SIGNAL PEPTIDE; SOX9 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CARDIOVASCULAR SYSTEM; CARTILAGE; CELL MATURATION; CHONDROGENESIS; CONTROLLED STUDY; DEFENSE MECHANISM; MORPHOGENESIS; MOUSE; NONHUMAN; SCLEROTOME; UPREGULATION; VASCULAR SMOOTH MUSCLE; ACTIVE TRANSPORT; ANIMAL; CARTILAGE CELL; CELL LINEAGE; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; MALE; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; TIME FACTOR;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CALCIUM-BINDING PROTEINS; CARTILAGE; CELL LINEAGE; CHONDROCYTES; CHONDROGENESIS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MALE; MEMBRANE PROTEINS; MICE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, NOTCH; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 84919494832     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2014.11.023     Document Type: Article

References (52)

1. Ailawadi G., Moehle C.W., Pei H., Walton S.P., Yang Z., Kron I.L., Lau C.L., Owens G.K. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J.Thorac. Cardiovasc. Surg. 2009, 138:1392-1399.
2. Airik R., Trowe M.O., Foik A., Farin H.F., Petry M., Schuster-Gossler K., Schweizer M., Scherer G., Kist R., Kispert A. Hydroureternephrosis due to loss of Sox9-regulated smooth muscle cell differentiation of the ureteric mesenchyme. Hum. Mol. Genet. 2010, 19:4918-4929.
3. Alexander M.R., Owens G.K. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu. Rev. Physiol. 2012, 74:13-40.
4. Bell D.M., Leung K.K., Wheatley S.C., Ng L.J., Zhou S., Ling K.W., Sham M.H., Koopman P., Tam P.P., Cheah K.S. SOX9 directly regulates the type-II collagen gene. Nat. Genet. 1997, 16:174-178.
5. Benedito R., Roca C., Sörensen I., Adams S., Gossler A., Fruttiger M., Adams R.H. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 2009, 137:1124-1135.
6. Bi W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Sox9 is required for cartilage formation. Nat. Genet. 1999, 22:85-89.
7. Borggrefe T., Liefke R. Fine-tuning of the intracellular canonical Notch signaling pathway. Cell Cycle 2012, 11:264-276.
8. Brent A.E., Tabin C.J. Developmental regulation of somite derivatives: muscle, cartilage and tendon. Curr. Opin. Genet. Dev. 2002, 12:548-557.
9. Chen S., Tao J., Bae Y., Jiang M.M., Bertin T., Chen Y., Yang T., Lee B. Notch gain of function inhibits chondrocyte differentiation via Rbpj-dependent suppression of Sox9. J.Bone Miner. Res. 2013, 28:649-659.
10. DeBakey M.E., Glaeser D.H. Patterns of atherosclerosis: effect of risk factors on recurrence and survival-analysis of 11,890 cases with more than 25-year follow-up. Am. J. Cardiol. 2000, 85:1045-1053.
11. Doi H., Iso T., Sato H., Yamazaki M., Matsui H., Tanaka T., Manabe I., Arai M., Nagai R., Kurabayashi M. Jagged1-selective notch signaling induces smooth muscle differentiation via a RBP-Jkappa-dependent pathway. J.Biol. Chem. 2006, 281:28555-28564.
12. Domenga V., Fardoux P., Lacombe P., Monet M., Maciazek J., Krebs L.T., Klonjkowski B., Berrou E., Mericskay M., Li Z., et al. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 2004, 18:2730-2735.
13. Feng X., Krebs L.T., Gridley T. Patent ductus arteriosus in mice with smooth muscle-specific Jag1 deletion. Development 2010, 137:4191-4199.
14. Fischer A., Schumacher N., Maier M., Sendtner M., Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 2004, 18:901-911.
15. Furumatsu T., Shukunami C., Amemiya-Kudo M., Shimano H., Ozaki T. Scleraxis and E47 cooperatively regulate the Sox9-dependent transcription. Int. J. Biochem. Cell Biol. 2010, 42:148-156.
16. Gadson P.F., Dalton M.L., Patterson E., Svoboda D.D., Hutchinson L., Schram D., Rosenquist T.H. Differential response of mesoderm- and neural crest-derived smooth muscle to TGF-beta1: regulation of c-myb and alpha1 (I) procollagen genes. Exp. Cell Res. 1997, 230:169-180.
17. Galvin K.M., Donovan M.J., Lynch C.A., Meyer R.I., Paul R.J., Lorenz J.N., Fairchild-Huntress V., Dixon K.L., Dunmore J.H., Gimbrone M.A., et al. A role for smad6 in development and homeostasis of the cardiovascular system. Nat. Genet. 2000, 24:171-174.
18. Gridley T. Notch signaling in the vasculature. Curr. Top. Dev. Biol. 2010, 92:277-309.
19. Grogan S.P., Olee T., Hiraoka K., Lotz M.K. Repression of chondrogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site. Arthritis Rheum. 2008, 58:2754-2763.
20. Guo D.C., Pannu H., Tran-Fadulu V., Papke C.L., Yu R.K., Avidan N., Bourgeois S., Estrera A.L., Safi H.J., Sparks E., et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat. Genet. 2007, 39:1488-1493.
21. High F.A., Zhang M., Proweller A., Tu L., Parmacek M.S., Pear W.S., Epstein J.A. An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J.Clin. Invest. 2007, 117:353-363.
22. High F.A., Lu M.M., Pear W.S., Loomes K.M., Kaestner K.H., Epstein J.A. Endothelial expression of the Notch ligand Jagged1 is required forvascular smooth muscle development. Proc. Natl. Acad. Sci. USA 2008, 105:1955-1959.
23. Hofmann J.J., Zovein A.C., Koh H., Radtke F., Weinmaster G., Iruela-Arispe M.L. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome. Development 2010, 137:4061-4072.
24. Hofmann J.J., Briot A., Enciso J., Zovein A.C., Ren S., Zhang Z.W., Radtke F., Simons M., Wang Y., Iruela-Arispe M.L. Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome. Development 2012, 139:4449-4460.
25. Lenk G.M., Tromp G., Weinsheimer S., Gatalica Z., Berguer R., Kuivaniemi H. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 2007, 8:237.
26. Lindsay M.E., Dietz H.C. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 2011, 473:308-316.
27. Majesky M.W. Developmental basis of vascular smooth muscle diversity. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1248-1258.
28. Manderfield L.J., High F.A., Engleka K.A., Liu F., Li L., Rentschler S., Epstein J.A. Notch activation of Jagged1 contributes to the assembly of the arterial wall. Circulation 2012, 125:314-323.
29. Matthews B.G., Grcevic D., Wang L., Hagiwara Y., Roguljic H., Joshi P., Shin D.G., Adams D.J., Kalajzic I. Analysis of alphaSMA-labeled progenitor cell commitment identifies notch signaling as an important pathway in fracture healing. J.Bone Miner. Res. 2014, 29:1283-1294.
30. Mead T.J., Yutzey K.E. Notch signaling and the developing skeleton. Adv. Exp. Med. Biol. 2012, 727:114-130.
31. Miano J.M., Long X., Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am. J. Physiol. Cell Physiol. 2007, 292:C70-C81.
32. Morrow D., Scheller A., Birney Y.A., Sweeney C., Guha S., Cummins P.M., Murphy R., Walls D., Redmond E.M., Cahill P.A. Notch-mediated CBF-1/RBP-Jkappa-dependent regulation of human vascular smooth muscle cell phenotype invitro. Am. J. Physiol. Cell Physiol. 2005, 289:C1188-C1196.
33. Noseda M., Fu Y., Niessen K., Wong F., Chang L., McLean G., Karsan A. Smooth Muscle alpha-actin is a direct target of Notch/CSL. Circ. Res. 2006, 98:1468-1470.
34. Nus M., MacGrogan D., Martínez-Poveda B., Benito Y., Casanova J.C., Fernández-Avilés F., Bermejo J., de la Pompa J.L. Diet-induced aortic valve disease in mice haploinsufficient for the Notch pathway effector RBPJK/CSL. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1580-1588.
35. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
36. Owens A.P., Subramanian V., Moorleghen J.J., Guo Z., McNamara C.A., Cassis L.A., Daugherty A. Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3. Circ. Res. 2010, 106:611-619.
37. Pannu H., Tran-Fadulu V., Papke C.L., Scherer S., Liu Y., Presley C., Guo D., Estrera A.L., Safi H.J., Brasier A.R., et al. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum. Mol. Genet. 2007, 16:2453-2462.
38. Parmacek M.S. Myocardin-not quite MyoD. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1535-1537.
39. Pouget C., Pottin K., Jaffredo T. Sclerotomal origin of vascular smooth muscle cells and pericytes in the embryo. Dev. Biol. 2008, 315:437-447.
40. Proweller A., Pear W.S., Parmacek M.S. Notch signaling represses myocardin-induced smooth muscle cell differentiation. J.Biol. Chem. 2005, 280:8994-9004.
41. Ruchoux M.M., Guerouaou D., Vandenhaute B., Pruvo J.P., Vermersch P., Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. 1995, 89:500-512.
42. Speer M.Y., Yang H.Y., Brabb T., Leaf E., Look A., Lin W.L., Frutkin A., Dichek D., Giachelli C.M. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ. Res. 2009, 104:733-741.
43. Tang Y., Urs S., Liaw L. Hairy-related transcription factors inhibit Notch-induced smooth muscle alpha-actin expression by interfering with Notch intracellular domain/CBF-1 complex interaction with the CBF-1-binding site. Circ. Res. 2008, 102:661-668.
44. Topouzis S., Majesky M.W. Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-beta. Dev. Biol. 1996, 178:430-445.
45. Turlo K.A., Noel O.D., Vora R., LaRussa M., Fassler R., Hall-Glenn F., Iruela-Arispe M.L. An essential requirement for β1 integrin in the assembly of extracellular matrix proteins within the vascular wall. Dev. Biol. 2012, 365:23-35.
46. Wang Z., Wang D.Z., Hockemeyer D., McAnally J., Nordheim A., Olson E.N. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 2004, 428:185-189.
47. Wang T., Baron M., Trump D. An overview of Notch3 function in vascular smooth muscle cells. Prog. Biophys. Mol. Biol. 2008, 96:499-509.
48. Wang Q., Zhao N., Kennard S., Lilly B. Notch2 and Notch3 function together to regulate vascular smooth muscle development. PLoS ONE 2012, 7:e37365.
49. Wasteson P., Johansson B.R., Jukkola T., Breuer S., Akyürek L.M., Partanen J., Lindahl P. Developmental origin of smooth muscle cells in the descending aorta in mice. Development 2008, 135:1823-1832.
50. Xu Z., Ji G., Shen J., Wang X., Zhou J., Li L. SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation. Biochem. Biophys. Res. Commun. 2012, 422:285-290.
51. Yoshida T., Sinha S., Dandré F., Wamhoff B.R., Hoofnagle M.H., Kremer B.E., Wang D.Z., Olson E.N., Owens G.K. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ. Res. 2003, 92:856-864.
52. Zeng L., Kempf H., Murtaugh L.C., Sato M.E., Lassar A.B. Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis. Genes Dev. 2002, 16:1990-2005.